HIV viral suppression is a positive medical outcome which indicates viral control and inability to transmit infection. It is usually achieved through antiretroviral therapy. There is a lack of research into the psychosocial factors affecting HIV viral suppression, such as perceived neighborhood social cohesion, or how connected the subject feels to their neighbors.
To fill this gap, CUNY SPH alumna Ellen Wiewel led an analysis with faculty Luisa Borrell, Heidi Jones and Andrew Maroko and researchers from the New York City Department of Health and Mental Hygiene into whether perceived neighborhood social cohesion was associated with better medical outcomes among New Yorkers newly diagnosed with HIV infection.
The researchers used data from the New York City HIV surveillance registry, which includes all persons reported with HIV in the city since 2000 and their HIV-related laboratory test results, plus interviews of a stratified random sample of persons who were diagnosed with the virus between 2006 and 2012. Perceived neighborhood social cohesion did not appear to influence achievement of suppression among the 92 persons in the analysis.
“We had data from a relatively small and healthy population, and we weren’t able to demonstrate a consistent association between neighborhood social cohesion and viral suppression,” says Wiewel.
Future studies could explore whether cohesion has varying effects on medication adherence among populations of New Yorkers with HIV, and whether cohesion influences maintenance of viral suppression after its initial achievement, Wiewel adds.
Sustained viral suppression lower among blacks with HIV
Ellen W Wiewel et al. Neighborhood social cohesion and viral suppression after HIV diagnosis, Journal of Health Psychology (2018). DOI: 10.1177/1359105318810088
The City University of New York
Testing the connection between neighborhood cohesion and viral suppression among HIV-positive New Yorkers (2018, December 19)
retrieved 12 February 2019
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- Hickenlooper Expanded Medicaid, Created State-Run Marketplace To Insure Nearly All Coloradans
- Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs
- Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
- Adhesive gel bonds to eye surface, could repair injuries without surgery
- The future of genomics: A podcast featuring Stanford geneticists
- As Syphilis Invades Rural America, A Fraying Health Safety Net Is Failing To Stop It
- APOE gene impacts sleep depending on gender and severity of Alzheimer’s
- PCORI’s newly approved awards focus on cancer pain and opioid use disorders
- New tool provides a standard way to measure effects of caring for survivors of TBI
- Smartphone use risks eye examination misdiagnosis
- How drug-resistant bugs grow in CF patients’ lungs
- Gordana Vunjak-Novakovic Elected to American Academy of Arts & Sciences
- Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
- Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
- New estimation method assesses natural variations in sex ratio at birth
- UTA scientist receives $1.17 million grant for cancer research
- Coagulation factor VIIa prevents bleeds in hemophilia animal models
- Researchers identify risk factors for severe infection after knee replacement
- Mass drug administration can offer community-level protection against malaria
- FDA’s added sugar label could have substantial health and cost-saving benefits